The Brain Tumour Charity is a UK-based, Charity Commission registered, charity dedicated to funding research, raising awareness of brain tumours, reducing diagnosis times and providing support and information for people with brain tumours, their families and friends. In 2015 the charity published its new five year strategy 'Defeating Brain Tumours'. The charity's goals are to double survival of a brain tumour diagnosis within 10 years in the UK, and to halve the harm that brain tumours have on quality of life. History The Brain Tumour Charity, as it is today, was created after the merging of Brain Tumour UK, Samantha Dickson Brain Tumour Trust and the Joseph Foote Trust in 2013. The Samantha Dickson Brain Tumour Trust was started by Neil and Angela Dickson in 1996, who lost their daughter, Samantha, to a brain tumour when she was 16 years old. They had become aware of the lack of properly funded research into this cancer and were determined to try and remedy the situation. Andy Foote founded The Joseph Foote Fund in 2007 after losing his son, Joseph, to a brain tumour. The Foote family began raising funds for research into the causes and treatment of brain tumours – in its 12-year history The Joseph Foote Trust raised more than £2 million.In 1997, the UK Brain Tumour Society was founded, which later became Brain Tumour UK.The Brain Tumour Charity has grown rapidly since the merging, funding a diverse portfolio of research programmes, projects and clinical trials across the UK. Activities Research and research funding The Brain Tumour Charity currently fund a portfolio of research across the UK with the aim of doubling survival and reducing long term harm through improving the understand and complexities of brain tumours, better diagnostic techniques and new treatments. To achieve these goals, the charity focuses efforts on five priority areas that the charity believes will have the biggest effect for those affected, reflected in its five-year research strategy, 'A Cure Can't Wait': Accelerate – biobanking to accelerate research progress through centralised collection of, and access to, brain tumour tissue samples. Diagnose – diagnosing brain tumours earlier and more accurately for both children and adults. Understand – increasing understanding of the genetics and biology of tumour development to identify effective new treatments. Catalyse – translating laboratory discoveries into new and effective treatments that increase survival and quality of life. Enhance – enhancing care and quality of